RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 115 filers reported holding RELAY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $749,348 | -32.0% | 89,102 | +1.6% | 0.00% | – |
| Q2 2023 | $1,101,926 | -92.1% | 87,733 | -89.7% | 0.00% | -100.0% |
| Q1 2023 | $14,007,735 | -10.8% | 850,500 | -19.1% | 0.00% | 0.0% |
| Q4 2022 | $15,708,289 | +6.7% | 1,051,425 | +59.7% | 0.00% | 0.0% |
| Q3 2022 | $14,728,000 | -57.1% | 658,385 | -67.8% | 0.00% | -57.1% |
| Q2 2022 | $34,293,000 | -43.3% | 2,047,352 | +1.3% | 0.01% | -30.0% |
| Q1 2022 | $60,474,000 | -1.5% | 2,020,514 | +1.1% | 0.01% | 0.0% |
| Q4 2021 | $61,375,000 | +38.3% | 1,998,548 | +42.0% | 0.01% | +25.0% |
| Q3 2021 | $44,389,000 | -4.3% | 1,407,841 | +11.0% | 0.01% | 0.0% |
| Q2 2021 | $46,403,000 | +58.8% | 1,268,187 | +50.1% | 0.01% | +60.0% |
| Q1 2021 | $29,216,000 | +389.7% | 845,104 | +488.8% | 0.01% | +400.0% |
| Q4 2020 | $5,966,000 | -36.6% | 143,531 | -35.0% | 0.00% | -50.0% |
| Q3 2020 | $9,404,000 | – | 220,788 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 6,923,574 | $58,227,257 | 6.44% |
| Finepoint Capital LP | 870,870 | $7,324,017 | 3.65% |
| Nextech Invest Ltd. | 1,196,409 | $10,061,800 | 3.05% |
| MPM BioImpact LLC | 1,352,133 | $11,371,439 | 3.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $234,680,739 | 1.93% |
| EcoR1 Capital, LLC | 4,163,824 | $35,017,760 | 1.18% |
| Integral Health Asset Management, LLC | 800,000 | $6,728,000 | 0.93% |
| Alphabet Inc. | 1,568,753 | $13,193,212 | 0.85% |
| HARBOURVEST PARTNERS LLC | 296,402 | $2,492,741 | 0.85% |
| Boxer Capital, LLC | 1,819,132 | $15,298,900 | 0.81% |